AstraZeneca's FluMist Home, a nasal flu vaccine available for at-home use, aims to improve vaccination rates among children, especially those afraid of needles. Experts discuss its effectiveness and accessibility.
HHS Secretary Robert F. Kennedy Jr. has sparked outrage by canceling $500 million in mRNA vaccine research grants, citing questionable data. Experts warn this could hinder public health efforts and the future of vaccine technology.
The NIH's Jay Bhattacharya argues that public distrust led to the cancellation of mRNA vaccine contracts. This statement contrasts with Health Secretary Kennedy's claims about vaccine safety and efficacy.
The newly appointed vaccine advisory committee by Health Secretary Robert F. Kennedy Jr. is set to review childhood immunization practices, raising concerns among health experts about the implications for public health.
The Nimbus variant is causing a stir with familiar COVID-19 symptoms and a surge in painful sore throats. Experts weigh in on its spread and vaccine efficacy. Stay informed and protected!
A groundbreaking trial reveals that Mounjaro is more effective than Wegovy for weight loss, achieving a 20% reduction over 72 weeks compared to Wegovy's 14%. Discover the implications for obesity treatment!
Moderna's combined Covid and flu vaccine has outperformed traditional shots in a recent phase 3 trial, generating higher antibody levels and showing promise for dual protection against both viruses.
In a groundbreaking move, HHS Secretary Robert F. Kennedy Jr. mandates new vaccines to undergo placebo testing, raising ethical questions and altering vaccine approval protocols. Is this the future of vaccine safety?
A new review from the U.S. Department of Health reveals alarming evidence against medical interventions for children with gender dysphoria, emphasizing significant risks and ethical concerns.
Robert F. Kennedy Jr. faces backlash for misleading claims about the measles vaccine's safety and efficacy while urging vaccination amidst an ongoing outbreak. Experts challenge his statements.
